PB2017: CLINICAL OUTCOMES BY SF3B1 MUTATION STATUS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES RETREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS

Detalles Bibliográficos
Autores principales: Garcia-Manero, Guillermo, Matsuno, Rayna K., Mcbride, Ali, Makinde, Adeola Y, Brown, Thomas D., Idryo, Danny, Broome, Ronda, Herriman, Autumn, Wilkinson, Kristiana, Walters, Sheetal, Schrag, Andrew, Mohammed, Hina, Izano, Monika A., Mukherjee, Sudipto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429899/
http://dx.doi.org/10.1097/01.HS9.0000974880.20066.a9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429899/
http://dx.doi.org/10.1097/01.HS9.0000974880.20066.a9

Ejemplares similares